{"id":1892,"date":"2018-09-15T16:01:02","date_gmt":"2018-09-15T13:01:02","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=1892"},"modified":"2026-10-30T13:29:52","modified_gmt":"2026-10-30T11:29:52","slug":"iasis-pharma-three-new-manufacturing-facilities-completion","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-three-new-manufacturing-facilities-completion\/","title":{"rendered":"IASIS PHARMA THREE NEW MANUFACTURING FACILITIES COMPLETION"},"content":{"rendered":"<p>All three new dedicated and separated production Facilities are being completed in Q4 2018, within the 45.000m<sup>2<\/sup> of the property, operating under the strictest <strong>cGMPs<\/strong>:<\/p>\n<p><strong>&#8211; Facility One: Pharma Grade Effervescent Unit<img decoding=\"async\" class=\"wp-image-1765 alignright\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b-300x270.jpg\" alt=\"facility-one_b\" width=\"180\" height=\"162\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b-120x108.jpg 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b-200x180.jpg 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b-300x270.jpg 300w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b-400x360.jpg 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b-500x450.jpg 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b-600x540.jpg 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b-700x631.jpg 700w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b-768x692.jpg 768w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b-800x721.jpg 800w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-ONE_b.jpg 806w\" sizes=\"(max-width: 180px) 100vw, 180px\" \/><\/strong><br \/>\nState-of-the-art facility, equipped with entirely new European-made machinery and equipment, capable of producing in both:<br \/>\n<strong>&#8211; Tube filling presentation<br \/>\n&#8211; Strip \/ blister presentation<\/strong><br \/>\n<strong><br \/>\n<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>&#8211; Facility Two: Conventional medicines: tablets \/ capsules \/ sachets\u00a0<img decoding=\"async\" class=\"alignright wp-image-1769\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-TWO-300x169.jpg\" alt=\"facility-two\" width=\"200\" height=\"112\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-TWO-120x67.jpg 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-TWO-200x112.jpg 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-TWO-300x169.jpg 300w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-TWO-400x225.jpg 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-TWO-500x281.jpg 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-TWO-600x337.jpg 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-TWO.jpg 683w\" sizes=\"(max-width: 200px) 100vw, 200px\" \/><\/strong><br \/>\nState-of-the-art facility, equipped with entirely new European \u2013 made machinery and equipment to produce tablets, capsules and sachets.<\/p>\n<p><span style=\"color: #ffffff;\">_<\/span><\/p>\n<p><span style=\"color: #ffffff;\">_<\/span><\/p>\n<p><strong>&#8211; Facility Three: liquids \/ syrups \/ suspensions \/ nasal sprays \/<img decoding=\"async\" class=\"alignright wp-image-1767\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-THREE_c-300x200.jpg\" alt=\"facility-three_c\" width=\"200\" height=\"133\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-THREE_c-120x80.jpg 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-THREE_c-200x133.jpg 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-THREE_c-300x200.jpg 300w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-THREE_c-400x267.jpg 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-THREE_c-500x333.jpg 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/10\/FACILITY-THREE_c.jpg 591w\" sizes=\"(max-width: 200px) 100vw, 200px\" \/><br \/>\n<\/strong><strong><span style=\"color: #ffffff;\">____________<\/span>creams \/ ointments \/ gels\u00a0<\/strong><\/p>\n<p>The Liquids\u2019 production line is entirely new and equipped to produce a wide range of products, from solutions to syrups and suspensions.<\/p>\n<p><strong>Creams \/ ointments \/ gels: production is scheduled for end 2019.<\/strong><\/p>\n<p><span style=\"color: #ffffff;\">_<\/span><\/p>\n<p><strong>IASIS PHARMA<\/strong> new administrative offices, as well as modern <strong>Warehousing Facilities<\/strong>, are also being built within the new manufacturing site. 2.500m<sup>2 <\/sup>state-of-the-art warehousing facilities are in direct connection with the Production facilities and the Quality Control Department (operating under <strong>GLPs<\/strong>), guaranteeing safety, efficiency, integrity and speed in both management and delivery, under the strictest <strong>GDPs<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>All three new dedicated and separated production Facilities are being completed in Q4 2018, within the 45.000m2 of the property, operating under the strictest cGMPs: &#8211; Facility One: Pharma Grade Effervescent Unit State-of-the-art facility, equipped with entirely new European-made machinery and equipment, capable of producing in both: &#8211; Tube filling presentation &#8211; Strip \/ blister  [&#8230;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,145],"tags":[],"class_list":["post-1892","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-company-news"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-uw","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/1892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=1892"}],"version-history":[{"count":11,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/1892\/revisions"}],"predecessor-version":[{"id":1904,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/1892\/revisions\/1904"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=1892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=1892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=1892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}